FDA Grants Clearance for OGT’s AML/MDS FISH Probes
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden.
Read MorePosted by Chaunie Brusie | Feb 5, 2019 | Culture Media, Leukemia |
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden.
Read MorePosted by Steve Halasey | Jan 10, 2019 | Research, Specimen Collection & Handling |
With three NCI grants, BioFluidica is investigating chip-based liquid biopsy technologies for the detection of cancer and related genetic variants.
Read MorePosted by Steve Halasey | Nov 12, 2018 | Cancer, Disease States, Lung Cancer, Molecular Diagnostics |
Droplet digital PCR is rapidly becoming an invaluable tool in cancer treatment research.
Read MorePosted by Melissa Mayer | Aug 30, 2018 | Prenatal Testing, Software |
This month’s Product News section features products from Qiagen, ELITechGroup Biomedical Systems, and DiaSorin Molecular.
Read MorePosted by Melissa Mayer | Aug 6, 2018 | Leukemia, Software |
New applications include customizable QIAact target enrichment panels for next-generation sequencing of more than 13 hereditary disease groups.
Read More